Abstract C014: A novel TCRβ-directed IL-2 fusion molecule promotes stem-like CD8+ T cells with self-renewing properties in the peripheral lymphoid tissue, further expanded by HDAC inhibition to elicit a sustained anti-tumor therapeutic response